Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05059691 · ClinicalTrials.gov registry record
Three-Dimensional Fluoroscopic Guidance During Transbronchial Cryobiopsy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 5
- Enrollment target
NCT05059691: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT05059691 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05059691 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This study assesses the effectiveness of transbronchial cryobiopsy guided by 3-dimensional fluoroscopy. Transbronchial cryobiopsy is a procedure to collect lung tissue. The main side effect seen after a transbronchial cryobiopsy is pneumothorax (air leaking out of the lung, which may cause a completely or partially collapsed lung). The standard imaging scans used during this procedure are 2-dimensional (like a photo), which can make it difficult for the doctor to know exactly where the biopsy tool is during the procedure. If the exact location of the device is not clear, a patient can be at a higher risk of pneumothorax. Using a 3-dimensional imaging technique may help to decrease the risk of pneumothorax during transbronchial cryobiopsy.
Interventions
- OTHER Electronic Health Record Review
- PROCEDURE Transbronchial Cryobiopsy Guided by Three-Dimensional Fluoroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-03-30 |
| Est. Completion | 2023-05-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05059691
The ClinicalTrials.gov registry entry for NCT05059691 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electronic Health Record Review is the first listed.
NCT05059691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05059691 about?
NCT05059691 is a clinical study titled "Three-Dimensional Fluoroscopic Guidance During Transbronchial Cryobiopsy". This study assesses the effectiveness of transbronchial cryobiopsy guided by 3-dimensional fluoroscopy. Transbronchial cryobiopsy is a procedure to collect lung tissue. The main side effect seen after a transbronchial cryobiopsy is pneumothorax (air leaking out of the lung, which may cause a complet...
What is the current status of trial NCT05059691?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2021-03-30. Estimated completion is 2023-05-11.
What interventions are being tested in trial NCT05059691?
The interventions under investigation include: Electronic Health Record Review (OTHER), Transbronchial Cryobiopsy Guided by Three-Dimensional Fluoroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT05059691?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.